“This isn't simply a cancer story. It's an equity story,” said Meredith Cummins, CEO of NeuroEndocrine Cancer Australia. “Where you live, how far you are from specialist care, and your socioeconomic circumstances are increasingly influencing outcomes for people diagnosed with neuroendocrine cancer.” …
Widening inequality threatens outcomes for Australians with neuroendocrine cancer
July 14, 2026 Latest News
Latest Video
New Stories
-
Patients move to reclaim access agenda ahead of sector negotiations
July 15, 2026 - - Latest News -
Minister recommits to keeping MS medicines on the PBS while awaiting formal advice
July 15, 2026 - - Latest News -
Budget outlook now hangs on disability savings, but what about pharmaceuticals
July 15, 2026 - - Latest News -
Australian partnership advances gene therapy for Retinitis Pigmentosa
July 15, 2026 - - Latest News -
An opportunity to become a global destination for paediatric oncology trials
July 15, 2026 - - Latest News -
Widening inequality threatens outcomes for Australians with neuroendocrine cancer
July 14, 2026 - - Latest News -
Can GLP-1s be more transformative than AI - one person believes they already are
July 14, 2026 - - Latest News